Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb 761 in Mild Cognitive Impairment
NCT05594355Phase 4Unknown
- Sponsor
- Ace Alzheimer Center Barcelona
- Start
- Apr 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ginkgo biloba extract in Mild Cognitive Impairment (MCI), sponsored by Ace Alzheimer Center Barcelona. Status: unknown.
02
Drugs
ginkgo biloba extract
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05594355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594355.